Skip to main content

Table 1 Overview of the definition of sponsor

From: Sponsorship in non-commercial clinical trials: definitions, challenges and the role of Good Clinical Practices guidelines

Guideline/regulation Year Sponsor’s definition
WHO GCP 1995 An individual, a company, an institution or an organization which takes responsibility for the initiation, management and/or financing of a clinical trial.
ICH GCP 1996 An individual, a company, an institution or an organization which takes responsibility for the initiation, management and/or financing of a clinical trial.
EU Directive 2002 An individual, company, institution or organization which takes responsibility for the initiation, management and/or financing of a clinical trial
Belgian Law 2004 An individual, company, institution or organization which takes responsibility for the initiation, management and/or financing of a clinical trial
UK Regulation 2004 Takes responsibility for the initiation, management and financing (or arranging the financing) of that trial.
South Africa GCP 2006 An individual, company, institution, or organisation which takes responsibility for the initiation, management, and/or financing of a clinical trial
Uganda Guidelines 2007 The sponsor is responsible for providing all the necessary financial support for initiation and completion of the research project
Uganda Guidelines 2014 The sponsor as such is not defined
Ghana GCP 2013 An individual, company, institution or organization which takes responsibility for the initiation, management and/or financing of a trial. This excludes an individual company, institution or organization which has been requested to provide money for a trial and does not benefit in any way from the results of the trial
EU Regulation 2014 An individual, company, institution or organisation which takes responsibility for the initiation, the management and for setting up the financing of the clinical trial
Ethiopia GCP Not dated An individual, a company, an institution or an organization which takes responsibility for the initiation, management and/or financing of a clinical trial.